|Ms. Valérie Lorentz-Poinsot||Gen. Mang. & Exec. Director||821.58k||N/A||1969|
|Mr. Jean-Christophe Bayssat||Deputy GM, Chief Pharmacist & Director of Pharmaceutical Devel.||1.18M||N/A||1963|
|Mr. Bruno Grange||International Controller & Director||16.22k||N/A||1953|
|Eric Lambert||Admin. & Financial Director||N/A||N/A||N/A|
|David Soussan||Group Marketing Director||N/A||N/A||N/A|
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines; and proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum for the treatment of influenza symptoms; Stodal and Stodaline to treat coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for nursing babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's branded homeopathic medicines comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat ocular discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. It offers its products through distribution centers, pharmacy chains, wholesalers, supermarkets, drugstores, and health food stores. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Boiron SA’s ISS governance QualityScore as of 6 December 2019 is 10. The pillar scores are Audit: 5; Board: 9; Shareholder rights: 7; Compensation: 9.